A5084442370- Endometrial and Cervical Cancer Treatments
- Cervical Cancer and HPV Research
- Angiogenesis and VEGF in Cancer
- Breast Cancer Treatment Studies
- Uterine Myomas and Treatments
- Endometriosis Research and Treatment
- Ovarian cancer diagnosis and treatment
- HER2/EGFR in Cancer Research
- Colorectal Cancer Surgical Treatments
- Metastasis and carcinoma case studies
- Sarcoma Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
University of Milano-Bicocca
2015-2018
Yale University
2015
This retrospective study aimed to compare the sentinel lymph node (SLN) mapping results of methylene blue (MB) and indocyanine green (ICG) in women with early-stage endometrial or cervical cancer.From August 2011 March 2015, all consecutive patients stage I cancer who underwent SLN intracervical injection MB ICG using a 22-gauge spinal needle were included study. Radical simple hysterectomy bilateral pelvic and/or aortic lymphadenectomy was performed after mapping.Overall, 81 (64 17 cancer)...
Uterine serous carcinoma (USC) is an aggressive subtype of endometrial cancer that carries extremely poor prognosis. Up to 35 % USC may overexpress the epidermal growth factor receptor-2 (HER2/neu) at strong (i.e., 3+) level by immunohistochemistry (IHC) or harbor HER2/neu gene amplification fluorescence in situ hybridization (FISH). In this study, we assessed sensitivity a panel cell lines with and without dacomitinib (PF-00299804), irreversible pan-human receptor tyrosine kinase inhibitor....